Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial

Published:2017-12 Issue:10 Volume:40 Page:658-662
ISSN:2444-3824
Container-title:Gastroenterología y Hepatología (English Edition)
language:en
Short-container-title:Gastroenterología y Hepatología (English Edition)

Author:

Ramas Mercedes,Donday Maria G.,McNicholl Adrian G.,Gisbert Javier P.

Publisher

Elsevier BV

Reference42 articles.

1. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report;Malfertheiner;Gut,2017

2. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy;Di Giulio;Scand J Gastroenterol,2016

3. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients;Bai;J Dig Dis,2015

4. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration;Marshall;Lancet,1984

5. European Registry on H. pylori management (HPEUREG): first-line treatments and interim analysis of 11,272 patients;Mcnicholl;United Eur Gastroenterol J,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP